Brief: Diamedica Therapeutics Announces First Quarter 2022 Results
04/05/2022 21:58
May 4 (Reuters) - DiaMedica Therapeutics Inc DMAC.O :
* DIAMEDICA THERAPEUTICS PROVIDES A BUSINESS UPDATE AND
ANNOUNCES
FIRST QUARTER 2022 FINANCIAL RESULTS
* DIAMEDICA THERAPEUTICS INC - CASH RUNWAY INTO 2024
* DIAMEDICA THERAPEUTICS INC - QTRLY BASIC AND DILUTED NET
LOSS
PER SHARE $0.13
Source text for Eikon: ID:nBw6sd7PHa
Further company coverage: DMAC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DiaMedica Therapeutics
See all newsBrief: Diamedica Therapeutics Announces Enrollment Of 200Th Patient In Remedy2 Phase 2/3 Acute Ischemic Stroke Trial
DiaMedica Q2 net loss widen less than expected
DiaMedica Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
Brief: Diamedica Receives FDA Feedback On Dm199 Preeclampsia Nonclinical Program